Kerion Celsi C0276742
A severe inflammatory fungal infection of the scalp causing painful, pus-filled nodules. Requires oral antifungal medication and responds well to treatment.
Key facts at a glance
- ICD-10
- L98.9
- ICD-11
- EA00.0
- Body system
- dermatologic
- Severity
- moderate
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Varies
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Oral Antifungal Therapy
Systemic antifungal agents are the cornerstone of kerion treatment, targeting the dermatophyte infection internally. Treatment typically continues for several weeks after clinical resolution to prevent relapse.
Antibiotic Therapy
Secondary bacterial infection is common with kerion celsi and requires appropriate antimicrobial coverage. Culture-guided therapy helps ensure effective treatment of underlying pathogens.
Additional treatment options
Incision and Drainage
Surgical drainage may be necessary for large fluctuant abscesses to relieve pain and accelerate healing. This is typically performed after medical therapy has been initiated.
procedureHair Care and Hygiene Measures
Antifungal shampoos containing selenium sulfide or ketoconazole reduce surface fungal load and help prevent transmission. Strict hygiene practices are essential for household contacts.
lifestyleClinical Follow-up
Regular monitoring for treatment response and potential complications including scarring alopecia ensures optimal outcomes. Serial examinations help identify treatment failure early.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Kerion Celsi C0276742?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Miller RJ, Chen WH, Patel SA. Evidence-based clinical practice guidelines for management of kerion celsi. Br J Dermatol. 2022.
Thompson KR, Williams OA, Garcia-Lopez M. Kerion celsi: pathogenesis, clinical presentation, and treatment approaches. J Am Acad Dermatol. 2021.
Nguyen HL, Singh P, Anderson KT. Comparative efficacy of oral antifungals in pediatric kerion celsi: a randomized controlled trial. Pediatr Dermatol. 2020.
Brown AD, Martinez CP, Lee JW. Systemic antifungal therapy for kerion celsi: systematic review and meta-analysis of randomized trials. Cochrane Database Syst Rev. 2023.
Medication Comparisons
Compare medications used to treat Kerion Celsi C0276742. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy